Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome

Alihanoglu Y. I., Yildiz B. S., ÖZCAN E. E., Kilic D. I., Kuru D. S., Taskoylu O., ...Daha Fazla

WIENER KLINISCHE WOCHENSCHRIFT, cilt.127, sa.21-22, ss.864-870, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 127 Sayı: 21-22
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s00508-015-0854-z
  • Dergi Adı: WIENER KLINISCHE WOCHENSCHRIFT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.864-870
  • Anahtar Kelimeler: Metabolic syndrome, Homocysteine, Coronary flow rate, TIMI frame count, TIMI FRAME COUNT, PLASMA HOMOCYSTEINE, INSULIN-RESISTANCE, DIABETES-MELLITUS, CARDIOVASCULAR-DISEASE, MYOCARDIAL-INFARCTION, HEART-DISEASE, SLOW-FLOW, MEN, HYPERHOMOCYSTEINEMIA
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background Metabolic syndrome (MS) refers to a group of cardiovascular risk factors associated with endothelial dysfunction and impaired coronary blood flow (CBF). Homocysteine (Hcy) is another risk factor for the development of insulin resistance and endothelial dysfunction. However, the relationship between Hcy levels and CBF in patients with MS has not been investigated specifically. In the present study, we aimed to evaluate the relationship between Hcy levels and CBF in MS patients with normal coronary arteries.